Viatris Inc. Common Stock (VTRS) Stock Price

VTRSStock

$16.72+55.31%52W

Market Cap$19.20B

P/E—

PEG Ratio1.05

Div yield2.70%

Beta0.88

VTRS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.19%

Price vs S&P 500 (4W)-10.44%

PEG Ratio1.05

VGM Score59.28

Indicated Dividend Yield (Annual)2.70%

P/CF (Annual)8.10x

Book Value / Share (Quarterly)$12.34

P/TBV (Annual)9.50x

Indicated Dividend (Annual)$0.48

Revenue Growth (3Y)-4.20%

Cash Flow / Share (Quarterly)$1.57

Payout Ratio (TTM)79.14%

Price vs S&P 500 (YTD)20.89%

Gross Margin (TTM)40.34%

Net Profit Margin (TTM)-2.79%

EPS (TTM)$-0.36

10-Day Avg Trading Volume9.01M

EPS Excl Extra (TTM)$-0.36

Revenue Growth (5Y)3.66%

EPS (Annual)$-3.00

Dividend / Share (Annual)$0.48

ROI (Annual)-12.07%

Gross Margin (Annual)39.55%

Net Profit Margin (5Y Avg)-4.57%

Cash / Share (Quarterly)$1.18

Revenue Growth QoQ (YoY)4.88%

ROA (Last FY)-9.45%

Revenue Growth TTM (YoY)4.40%

EBITD / Share (TTM)$2.29

ROE (5Y Avg)-4.67%

Operating Margin (TTM)-0.91%

Cash Flow / Share (Annual)$1.61

P/B Ratio1.31x

P/B Ratio (Quarterly)1.30x

Net Income / Employee (Annual)$-117,200

EV / Revenue (TTM)2.12x

Net Interest Coverage (TTM)-6.78x

ROA (TTM)-1.12%

EV / EBITDA (TTM)11.69x

EPS Incl Extra (Annual)$-3.00

Current Ratio (Annual)1.38x

Quick Ratio (Quarterly)0.83x

3-Month Avg Trading Volume10.82M

52-Week Price Return55.31%

EV / Free Cash Flow (Annual)16.87x

Revenue / Employee (TTM)$491,200

Tangible BV / Share (Quarterly)$0.51

P/S Ratio (Annual)1.31x

Asset Turnover (Annual)0.38x

52-Week High$18.39

Operating Margin (5Y Avg)-1.79%

EPS Excl Extra (Annual)$-3.00

CapEx CAGR (5Y)-7.35%

Tangible BV CAGR (5Y)29.84%

26-Week Price Return3.05%

Quick Ratio (Annual)0.70x

13-Week Price Return0.49%

Total Debt / Equity (Annual)0.98x

Current Ratio (Quarterly)1.58x

Enterprise Value$31.21B

Revenue / Share Growth (5Y)-9.28%

Asset Turnover (TTM)0.40x

Book Value / Share Growth (5Y)-7.64%

Revenue / Employee (Annual)$476,700

Inventory Turnover (Annual)2.20x

Pretax Margin (Annual)-25.63%

Cash / Share (Annual)$1.24

3-Month Return Std Dev29.66%

Gross Margin (5Y Avg)40.95%

Net Income / Employee (TTM)$-13,700

EBITDA CAGR (5Y)-56.10%

EBITDA Interim CAGR (5Y)-12.31%

ROE (Last FY)-23.89%

Net Interest Coverage (Annual)-0.38x

EPS Basic Excl Extra (Annual)$-3.00

P/FCF (TTM)10.35x

Receivables Turnover (TTM)4.98x

EV / Free Cash Flow (TTM)17.22x

Total Debt / Equity (Quarterly)0.94x

EPS Incl Extra (TTM)$-0.36

Receivables Turnover (Annual)5.44x

ROI (TTM)-1.42%

P/S Ratio (TTM)1.27x

Pretax Margin (5Y Avg)-2.99%

Revenue / Share (Annual)$12.21

Tangible BV / Share (Annual)$1.31

Forward P/E6.97x

Free OCF CAGR (5Y)27.44%

Price vs S&P 500 (52W)36.99%

Year-to-Date Return32.85%

5-Day Price Return2.29%

EPS Normalized (Annual)$-3.00

ROA (5Y Avg)-1.80%

Net Profit Margin (Annual)-24.58%

Month-to-Date Return-5.81%

Cash Flow / Share (TTM)$3.97

EBITD / Share (Annual)$0.03

Operating Margin (Annual)-19.34%

LT Debt / Equity (Annual)0.85x

P/CF (TTM)8.04x

ROI (5Y Avg)-2.33%

LT Debt / Equity (Quarterly)0.81x

EPS Basic Excl Extra (TTM)$-0.36

P/TBV (Quarterly)31.69x

Payout Ratio (Annual)28.47%

P/B Ratio (Annual)0.97x

Dividend / Share (TTM)$0.48

Inventory Turnover (TTM)2.15x

Pretax Margin (TTM)-4.49%

Book Value / Share (Annual)$12.78

Price vs S&P 500 (13W)-2.31%

Dividend Yield (TTM)2.97%

Beta0.88x

P/FCF (Annual)10.13x

Revenue / Share (TTM)$12.67

ROE (TTM)-2.79%

52-Week Low$9.43

vGradeB

gGradeC

mGradeB

vgmGradeC

VTRS Earnings Surprise History

Q2 250.62est. 0.56

Q3 250.67est. 0.62

Q4 250.57est. 0.53

Q1 260.59est. 0.50

Q2 260.69est. 0.60

VTRS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.83

3.82

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
VTRSViatris Inc. Common Stock	B	C	B	$16.72
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Viatris Inc. Common Stock

Viatris is a globally diversified pharmaceutical company formed in November 2020 through the merger of Pfizer's Upjohn division and Mylan, establishing itself as one of the world's largest generic drug manufacturers serving over 165 countries. The company generates approximately 60% of revenues from established pharmaceutical products including Lipitor, Norvasc, Lyrica, and Viagra, while the remaining 40% comes from generic drugs and biosimilars. Viatris operates across over 10 therapeutic areas, with strategic focus on dermatology, ophthalmology, and gastroenterology for future growth.